A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (BALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum: A Groupwide Phase III Study
This randomized phase III trial is studying how well combination chemotherapy works in
treating young patients with newly diagnosed acute lymphoblastic leukemia that is likely to
come back or spread. Drugs used in chemotherapy work in different ways to stop the growth of
cancer cells, either by killing the cells or by stopping them from dividing. Giving more
than one drug (combination chemotherapy) and giving the drugs in different doses and in
different combinations may kill more cancer cells.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.